CXCL12 and ovarian cancer: The reduction by mifepristone of adhesive capacity of ovarian cancer cells to fibronectin and Matrigel was attributed to the suppression of the activation by SDF-1 of adhesion molecules and the decline in the cell surface expression of functional adhesion molecules (Figure 5).